LUISA VEGA: Open Payments
NPI 1558772657 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,068 in 54 payments from 6 companies in 2025. Trend: 2023 $552 · 2024 $516 · 2025 $27,068
Speaker / faculty: $23,312Food & beverage: $1,950Travel & lodging: $1,727Education: $80
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 24 | $13,526 |
| Otsuka America Pharmaceutical, Inc. | 20 | $13,031 |
| Neurocrine BioSciences, Inc. | 4 | $227 |
| Teva Pharmaceuticals USA, Inc. | 4 | $140 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Indivior Inc. | 1 | $22 |
Products named: NUPLAZID, REXULTI, INGREZZA, COBENFY, AUSTEDO XR, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
